Israel Englander Avidity Biosciences, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 168,591 shares of RNA stock, worth $6.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,591

Previous 340,616 50.5%

Holding current value

$6.89 Million

Previous $3.08 Million 39.58%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $1.58 Million - $4.39 Million	-172,025 Reduced 50.5%	168,591 $4.3 Million
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $1.44 Million - $2.77 Million	295,476 Added 654.58%	340,616 $3.08 Million
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $479,386 - $782,727	45,140 New	45,140 $500,000
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $7.16 Million - $16.1 Million	711,532 Added 1828.52%	750,445 $16.7 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $601,594 - $911,731	38,913 New	38,913 $635,000

Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $270,552 - $453,080	-19,053 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $75,337 - $105,841	3,693 Added 24.04%	19,053 $453,000
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $131,841 - $183,024	7,260 Added 89.63%	15,360 $378,000
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $1.67 Million - $2.49 Million	-84,996 Reduced 91.3%	8,100 $200,000
Q1 2021 May 17, 2021	SELL	$20.28 - $28.15 $225,513 - $313,028	-11,120 Reduced 10.67%	93,096 $2.03 Million
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $2.58 Million - $3.66 Million	104,216 New	104,216 $2.66 Million
Q3 2020 Nov 16, 2020	SELL	$23.35 - $35.94 $5.28 Million - $8.12 Million	-226,044 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $6.02 Million - $7.12 Million	226,044 New	226,044 $6.39 Million

Others Institutions Holding RNA

# of Institutions

164

Shares Held

71.6M

Call Options Held

182K

Put Options Held

55K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.13B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account